REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Imunodiagnostika (Lithuania)

Main Activities: Scientific Research and Development Services | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: UAB Imunodiagnostika Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Self.co is a Europe-focused digital health and wellness company that provides at-home health testing solutions designed to make personal health monitoring accessible, private, and convenient. Operating under the legal entity UAB Imunodiagnostika in Lithuania, Self.co offers a range of self-testing kits covering areas such as hormone balance, vitamins, allergies, and general wellbeing. The company combines clinically validated laboratory analysis with an easy-to-use online platform, enabling customers to collect samples at home and receive clear, actionable results to support informed health decisions.

Headquarters
Rieses sen. Didziosios Rieses k. Moletu g. 16
Vilnius; Vilnius county; Postal Code: LT-14260

Contact Details: Purchase the UAB Imunodiagnostika report to view the information.

Basic Information
Total Employees:
Purchase the UAB Imunodiagnostika report to view the information.
Registered Capital:
Purchase the UAB Imunodiagnostika report to view the information.
Financial Auditors:
Purchase the UAB Imunodiagnostika report to view the information.
Incorporation Date:
May 15, 2013
Company Performance
Financial values in the chart are available after UAB Imunodiagnostika report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
67.2%
Total operating revenue
67.2%
Net Profit (Loss) for the Period
N/A
Total Equity
-94.29%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?